Biểu đồ giá cổ phiếu 02496.HK
YZYBIO-B (02496.HK)
Wuhan YZY Biopharma Co., Ltd.
HK$0
0%
$0
Thị trường đóng cửa: May 07, 16:00:00 HKT
Quay lại
Wuhan YZY Biopharma Co., Ltd. (02496.HK)
Thống kê chính
Giá đóng cửa trước
--
Giá mở cửa
--
Phạm vi ngày
-
Phạm vi 52 tuần
-
Khối lượng
--
Khối lượng trung bình
--
Tỷ suất cổ tức
--
EPS (TTM)
--
Vốn hóa thị trường
--
YZYBIO-B là gì?
Wuhan YZY Biopharma Co., Ltd. engages in the research, development, and industrialization of bispecific drugs. The company is headquartered in Wuhan, Hubei and currently employs 106 full-time employees. The company went IPO on 2023-09-25. The firm is committed to developing bispecific antibody (BsAb) based therapies for the treatment of cancer-related complications, cancer, and age-related eye diseases to address the medical needs in oncology and geriatric eye diseases. The firm's core product M701 is a recombinant BsAb that targets human cancer cell surface antigen EpCAM and human T cell surface antigen CD3. The firm's product pipeline also includes Y101D, Y332, Y225, and others.
